Gary Taylor

Stock Analyst at TD Cowen

(2.62)
# 1,997
Out of 5,179 analysts
148
Total ratings
51.52%
Success rate
0.61%
Average return

Stocks Rated by Gary Taylor

Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44$25
Current: $22.91
Upside: +9.12%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40$42
Current: $16.80
Upside: +150.00%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45$13
Current: $2.94
Upside: +325.17%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6$2
Current: $0.40
Upside: +404.80%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261$268
Current: $169.09
Upside: +58.50%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10$13
Current: $16.62
Upside: -21.78%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450$440
Current: $471.85
Upside: -6.75%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601$609
Current: $259.02
Upside: +135.12%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80$89
Current: $32.00
Upside: +178.13%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351$378
Current: $134.03
Upside: +182.03%
Maintains: Hold
Price Target: $183$220
Current: $184.04
Upside: +19.54%
Maintains: Hold
Price Target: $139$150
Current: $154.43
Upside: -2.87%
Maintains: Outperform
Price Target: $30$26
Current: $20.02
Upside: +29.87%
Upgrades: Outperform
Price Target: $39$35
Current: $11.49
Upside: +204.61%
Maintains: Outperform
Price Target: $564$585
Current: $286.39
Upside: +104.27%
Maintains: Market Perform
Price Target: $3$6
Current: $11.14
Upside: -46.14%
Maintains: Outperform
Price Target: $10$8
Current: $6.32
Upside: +26.58%
Upgrades: Outperform
Price Target: $242$329
Current: $261.96
Upside: +25.59%
Upgrades: Market Perform
Price Target: $7$3
Current: $1.75
Upside: +71.43%
Initiates: Market Perform
Price Target: $17
Current: $7.91
Upside: +114.92%
Downgrades: Underweight
Price Target: $28$20
Current: $191.86
Upside: -89.58%
Maintains: Neutral
Price Target: $33$20
Current: $20.50
Upside: -2.44%
Downgrades: Underweight
Price Target: n/a
Current: $2.86
Upside: -